Professional Documents
Culture Documents
Clinical Utility of CYP2C19 Genotyping To Guide Antiplatelet Therapy in Patients With An Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
Clinical Utility of CYP2C19 Genotyping To Guide Antiplatelet Therapy in Patients With An Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
Clinical Utility of CYP2C19 Genotyping To Guide Antiplatelet Therapy in Patients With An Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
Re-use and distribution is strictly not permitted, except for Open Access articles
atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023. Re-use and distribution is strictly not permitted, except for Open Access articles
atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023. Re-use and distribution is strictly not permitted, except for Open Access articles
atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023. Re-use and distribution is strictly not permitted, except for Open Access articles
atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023. Re-use and distribution is strictly not permitted, except for Open Access articles
atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023. Re-use and distribution is strictly not permitted, except for Open Access articles